Notify me when Kenneth R. Melani files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MDCX | Medicus Pharma Ltd. | Common Shares, no par value | 18.2% | $9.84M | -$227K | 3.25M | -2.26% | Melani Kenneth R. | Jun 30, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|